- Trials with a EudraCT protocol (55)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
55 result(s) found for: Hyperthermic.
Displaying page 1 of 3.
| EudraCT Number: 2012-000701-77 | Sponsor Protocol Number: AGO/2012/002 | Start Date*: 2012-05-03 | |||||||||||
| Sponsor Name:Ghent University Hospital | |||||||||||||
| Full Title: Cytoreduction followed by Normothermic versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion: a Phase II Study in Peritoneal Carcinomatosis | |||||||||||||
| Medical condition: Patients with peritoneal carcinomatosis from colorectal origin (including appendiceal mucinous neoplasms and the pseudomyxoma syndromes) amenable for cytoreduction and Hyperthermic Intraperitoneal ... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-002628-18 | Sponsor Protocol Number: HIVECI | Start Date*: 2013-12-16 |
| Sponsor Name:COMBAT MEDICAL LTD | ||
| Full Title: HIVEC (Hyperthermic IntraVEsical Chemotherapy) FOR PATIENTS WITH INTERMEDIATE RISK NMIBC COMPARED WITH STANDARD INTRAVESICAL INSTILLATION OF CHEMOTHERAPY AS ADYUVANT TREATMENT. A COMPARATIVE, PROS... | ||
| Medical condition: NON MUSCULAR INVASIVE BLADDER CANCER WITH INTERMEDIATE RISK OF RECURRENCE | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-004280-31 | Sponsor Protocol Number: 04/280507 | Start Date*: 2006-02-02 |
| Sponsor Name:University of Dundee | ||
| Full Title: Hyperthermic Intraperitoneal Chemotherapy - Gastric Cancer | ||
| Medical condition: Gastric Cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-004298-41 | Sponsor Protocol Number: Pancreathipec1.0. | Start Date*: 2017-05-25 |
| Sponsor Name:Hospital General Ciudad Real | ||
| Full Title: Intrabdominal hyperthermic chemotherapy using gemcitabine to treat pancreatic carcinomatosis | ||
| Medical condition: A population of malignant transformation stem cells, called tumor stem cells, extremely resistant to chemotherapeutic drugs, has been identified as the origin of pancreatic cancer. In our study, we... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-009467-59 | Sponsor Protocol Number: IJB-HIPEC-2009-01 | Start Date*: 2010-03-18 |
| Sponsor Name:Institut Jules Bordet | ||
| Full Title: Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy. | ||
| Medical condition: Inclusion criteria : 1. Histologically confirmed ovarian carcinoma or primary peritoneal carcinoma or Fallopian tube carcinoma. 2. FIGO stage III disease or only pleural stage IV disease 3. Age les... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001801-15 | Sponsor Protocol Number: FCO-HIP-2015-01 | Start Date*: 2015-10-08 | |||||||||||
| Sponsor Name:FIBICO | |||||||||||||
| Full Title: Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced c... | |||||||||||||
| Medical condition: Colorectal cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-000138-37 | Sponsor Protocol Number: PERISCOPE | Start Date*: 2013-09-25 | ||||||||||||||||
| Sponsor Name:NKI-AvL | ||||||||||||||||||
| Full Title: Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy | ||||||||||||||||||
| Medical condition: Gastric cancer with peritoneal carcinomatosis or positive peritoneal cytology. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2004-003898-86 | Sponsor Protocol Number: HL BOR 001 | Start Date*: 2005-03-07 | |||||||||||
| Sponsor Name:Institut jules Bordet | |||||||||||||
| Full Title: EVALUATION OF THE TREATMENT OF PERITONEAL CARCINOMATOSIS OF COLORECTAL ORIGIN THROUGH COMPLETE RESECTION AND HYPERTHERMIC INTRA-PERITONEAL PEROPERATIVE CHEMOTHERAPY (HIPEC) WITH OXALIPLATIN | |||||||||||||
| Medical condition: Peritoneal carcinomatosis secondary to a carcinoma of colorectal or appendicular origin | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-002850-38 | Sponsor Protocol Number: PI-0327-2013 | Start Date*: 2015-05-21 |
| Sponsor Name:FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DE CÓRDOBA | ||
| Full Title: EFFICACY AND SAFETY OF EARLY POSTOPERATIVE CHEMOTHERAPY INTRAPERITONEAL (EPIC) WITH PACLITAXEL IN THE RADICAL SURGERY TREATMENT OF OVARIAN PERITONEAL CARCINOMATOSIS | ||
| Medical condition: ovarian peritoneal carcinomatosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-004679-37 | Sponsor Protocol Number: GECOP-MMC | Start Date*: Information not available in EudraCT |
| Sponsor Name:Hospital Universitario de Fuenlabrada | ||
| Full Title: Phase IV multicentric clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with Mytomicin-C after complete surgical cytoreduction in patients with Colon Canc... | ||
| Medical condition: Surgical resection combined with intraperitoneal chemotherapy (CT) is the best treatment for selected patients with Peritoneal Metastases from colon cancer. However, the real role of intraperitonea... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002794-11 | Sponsor Protocol Number: NL49960.018.14 | Start Date*: 2014-12-08 |
| Sponsor Name:Academic Medical Center | ||
| Full Title: Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicenter trial | ||
| Medical condition: Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicenter trial | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-003244-76 | Sponsor Protocol Number: Prot-HIPEC-Ovar-201201.7 | Start Date*: 2014-07-11 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Feasibility of intraoperative hyperthermic intraperitoneal chemotherapy with carboplatin and paclitaxel in patients with advanced epithelial ovarian cancer – a combined phase I / II trial | ||
| Medical condition: Otherwise treatment-naive patients with epithelial ovarian cancer, FIGO III - IVa | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002480-94 | Sponsor Protocol Number: 69HCL17_0342 | Start Date*: 2021-07-21 | |||||||||||
| Sponsor Name:Hospices Civils de Lyon | |||||||||||||
| Full Title: Assessment of cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in first or secondary platinum-resistant recurrent ovarian epithelial cancer. HIPOVA-01 | |||||||||||||
| Medical condition: Patients with First or second recurrence of platin-resistant epithelial ovarian cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-001715-31 | Sponsor Protocol Number: EC-CG/AD-01/11 | Start Date*: 2011-12-13 |
| Sponsor Name:Fundación para la Formación e Investigación Sanitaria de la Región de Murcia | ||
| Full Title: Cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) in patients with peritoneal carcinomatosis from ovarian cancer , fallopian tube or primary peritoneal ... | ||
| Medical condition: Peritoneal carcinomatosis from ovarian cancer, fallopian tube or primary peritoneal carcinoma. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-001417-39 | Sponsor Protocol Number: FIBHGM-ECNC001-2022 | Start Date*: 2023-05-18 |
| Sponsor Name:Fundación para la investigación biomédica del Hospital Gregorio Marañón (FIBHGM) | ||
| Full Title: A phase IIb, double-blind clinical trial to compare the nephroprotection of cilastatin versus placebo in patients undergoing debulking surgery with intraoperative hyperthermic intraperitoneal chemo... | ||
| Medical condition: Reduction of acute renal damage (days 1-7) (creatinine levels and KDIGO scale) in patients treated with CRS+HIPEC-cisplatin during the immediate postoperative period. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002507-18 | Sponsor Protocol Number: CSET2019/2955 | Start Date*: 2020-04-10 | ||||||||||||||||
| Sponsor Name:Gustave Roussy | ||||||||||||||||||
| Full Title: Efficacy and feasibility of pasireotide to reduce clinically relevant digestive leakage after complete cytoreductive surgery (CRS) plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for perito... | ||||||||||||||||||
| Medical condition: Primary and secondary peritoneal malignancies | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-001478-27 | Sponsor Protocol Number: IRFMN-GCC-7813 | Start Date*: 2019-09-11 | |||||||||||
| Sponsor Name:Associazione Chirurghi Ospedalieri Italiani | |||||||||||||
| Full Title: Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in gastric carcinoma at high risk of peritoneal carcinomatosis. Short and long-term outcomes.... | |||||||||||||
| Medical condition: Patients with gastric carcinoma at high risk of developing peritoneal carcinomatosis, suitable to radical surgery. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-006809-29 | Sponsor Protocol Number: N21CCI | Start Date*: 2022-05-23 |
| Sponsor Name:NKI-AVL | ||
| Full Title: Body surface area-based vs concentration-based dosing of cisplatin for hyperthermic intraperitoneal chemotherapy (HIPEC) in women with advanced ovarian cancer | ||
| Medical condition: FIGO stage III high grade serous ovarian cancer, peritoneal cancer, or fallopian tube carcinoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-005980-83 | Sponsor Protocol Number: CRO-2007-23 | Start Date*: 2008-01-27 | |||||||||||
| Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO | |||||||||||||
| Full Title: MULTICENTRIC, PERSPECTIVE, RANDOMIZED TRIAL TO ASSESS THE INTRAOPERATIVE USE OF HYPERTHERMIC CHEMOTHERAPY IN LOCALLY ADVANCED NON SMALL CELL LUNG CANCER. COMPARISON BETWEEN LOCO-REGIONAL + SYSTEMIC... | |||||||||||||
| Medical condition: NON SMALL CELL LUNG CANCER PATIENTS | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-003357-29 | Sponsor Protocol Number: PROICM2019-08INT | Start Date*: 2019-12-03 |
| Sponsor Name:Institut Régional du Cancer de Montpellier (ICM) | ||
| Full Title: Intensive intraperitoneal therapy in advanced ovarian cancer combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) and postoperative intraperitoneal chemotherapy (I... | ||
| Medical condition: Patient with high-grade serous (high grade according to MD Anderson, grade II and III according to Silverman) ovarian or tubal or primitive peritoneal histologically proven cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
